SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-20-000024
Filing Date
2020-05-11
Accepted
2020-05-11 07:15:00
Documents
7
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm 8-K 31444
2 EXHIBIT 99.1 a200511pirspr.htm EX-99.1 15012
3 a200511pirspr001.jpg GRAPHIC 242006
4 a200511pirspr002.jpg GRAPHIC 286993
5 a200511pirspr003.jpg GRAPHIC 298833
6 a200511pirspr004.jpg GRAPHIC 127115
7 a200511pirspr005.jpg GRAPHIC 89856
  Complete submission text file 0001583648-20-000024.txt   1487162
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 20862577
SIC: 8731 Services-Commercial Physical & Biological Research